Synthesis and Biological Profiling of Seven Heparin and Heparan Sulphate Analogue Trisaccharides.


Journal

Biomolecules
ISSN: 2218-273X
Titre abrégé: Biomolecules
Pays: Switzerland
ID NLM: 101596414

Informations de publication

Date de publication:
25 Aug 2024
Historique:
received: 11 07 2024
revised: 07 08 2024
accepted: 23 08 2024
medline: 28 9 2024
pubmed: 28 9 2024
entrez: 28 9 2024
Statut: epublish

Résumé

Researchers are paying increasing attention to the strongly negatively charged heteropolysaccharides in cells, in the extracellular matrix or in the cell wall. Examples of such molecules are glycosaminoglycans (e.g., heparin, heparan sulphate). It is well known from the literature that heparin and its derivatives have anti-inflammatory, angiogenic, metastatic and growth factor inhibitory activity. Herein, we present the efficient synthesis of six non-glycosaminoglycan (Glc-GlcA-Glc-sequenced) and one heparin-related (GlcN-GlcA-Glc-sequenced) trisaccharides with various functional group patterns. The anti-inflammatory, antioxidant and cell growth-inhibitory/cytotoxic effects of the synthesized compounds were tested. Among the investigated molecules, we have found some derivatives with a promising anti-inflammatory and antioxidant effect.

Identifiants

pubmed: 39334821
pii: biom14091052
doi: 10.3390/biom14091052
pii:
doi:

Substances chimiques

Heparitin Sulfate 9050-30-0
Heparin 9005-49-6
Trisaccharides 0
Antioxidants 0
Anti-Inflammatory Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : National Research and Development and Innovation Office of Hungary
ID : FK 137924
Organisme : National Research and Development and Innovation Office of Hungary
ID : PD 134791
Organisme : National Research and Development and Innovation Office of Hungary
ID : FK 134725
Organisme : New National Excellence Program of the Ministry for Culture and Innovation from the source of the National Research, Development and Innovation Fund
ID : ÚNKP-23-4
Organisme : University of Debrecen Program for Scientific Publication

Auteurs

Fruzsina Demeter (F)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Zsófia Peleskei (Z)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Katalin Kútvölgyi (K)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Ágnes Rusznyák (Á)

Department of Molecular and Nanopharmaceutics, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.
Institute of Healthcare Industry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Ferenc Fenyvesi (F)

Department of Molecular and Nanopharmaceutics, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.

Richárd Kajtár (R)

Department of Pharmacodynamics, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.

Éva Sipos (É)

Department of Pharmacodynamics, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.

István Lekli (I)

Department of Pharmacodynamics, Faculty of Pharmacy, University of Debrecen, Nagyerdei Körút 98, H-4032 Debrecen, Hungary.

Petra Molnár (P)

Department of Immunology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Attila Gábor Szöllősi (AG)

Department of Immunology, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Erika Lisztes (E)

Department of Physiology, University of Debrecen, P.O. Box 22, H-4012 Debrecen, Hungary.

Balázs István Tóth (BI)

Department of Physiology, University of Debrecen, P.O. Box 22, H-4012 Debrecen, Hungary.
Department of Physiology, Medical School, University of Pécs, Szigeti út 12, H-7624 Pécs, Hungary.

Anikó Borbás (A)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
HUN-REN-DE Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Mihály Herczeg (M)

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.
HUN-REN-DE Molecular Recognition and Interaction Research Group, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH